Cambridge Investment Research Advisors, Inc. Hexo Corp. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 17, 2022	SELL	$0.17 - $0.26 $140 - $215	-829 Reduced 5.65%	13,833 $0
Q2 2022 Jul 13, 2022	SELL	$0.2 - $0.61 $47 - $143	-235 Reduced 1.58%	14,662 $3,000
Q1 2022 May 12, 2022	SELL	$0.48 - $0.74 $58 - $89	-121 Reduced 0.81%	14,897 $9,000
Q4 2021 Feb 03, 2022	BUY	$0.7 - $1.94 $461 - $1,280	660 Added 4.6%	15,018 $10,000
Q3 2021 Nov 02, 2021	SELL	$1.82 - $5.71 $11,025 - $34,591	-6,058 Reduced 29.67%	14,358 $26,000
Q2 2021 Aug 10, 2021	BUY	$5.22 - $7.33 $43,044 - $60,443	8,246 Added 67.76%	20,416 $118,000
Q1 2021 May 07, 2021	BUY	$4.0 - $10.28 $48,680 - $125,107	12,170 New	12,170 $78,000

Others Institutions Holding HEXO

# of Institutions

Shares Held

23.7K

Call Options Held

Put Options Held

View Full List

About HEXO Corp.

Ticker HEXO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 601,395,008
Description
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...

More about HEXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account